Evaluation of Effects of CBD Products on Anxiety Among U.S. Women
Launched by RADICLE SCIENCE · Oct 25, 2021
Trial Information
Current as of September 06, 2025
Completed
Keywords
ClinConnect Summary
Between October 1-7, 2020, women from across the US were recruited by Rae Wellness to participate in a 60-day in-home use test (IHUT) of various Cannabidiol (CBD) products. The inclusion criteria were: women; between the ages of 24-44; reported symptoms associated with at least 4 out of 6 health issues (stress; anxiety; pain; sleep issues; digestive issues; low libido). Individuals were excluded if they were pregnant or breastfeeding. 1,350 women were randomly selected to participate in the study. The participants were randomized to one of 9 groups in the IHUT (150 in each group): 8 groups ...
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • Self-identified female
- • Ages of 24 to 44 years
- • Reported symptoms associated with at least 4 out of 6 health issues (stress; anxiety; pain; sleep issues; digestive issues; low libido).
- Exclusion Criteria:
- • -Pregnant or breastfeeding
About Radicle Science
Radicle Science is an innovative clinical trial sponsor dedicated to advancing healthcare through the integration of cutting-edge technology and robust scientific research. Specializing in decentralized clinical trials, Radicle Science leverages real-world data and digital health solutions to enhance patient engagement and streamline study processes. Committed to transparency and collaboration, the company aims to accelerate the development of new therapies while ensuring rigorous adherence to regulatory standards. With a focus on improving health outcomes, Radicle Science is at the forefront of transforming the clinical research landscape.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Minneapolis, Minnesota, United States
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials